Where is biological therapy going?
The substantial progress in our understanding of molecular and cellular biology has allowed us to design biological therapeutics ('biologicals') with defined targets and effector functions. These biologicals have greatly contributed to our current knowledge of pathogenetic mechanisms in autoimmune d...
Spremljeno u:
| Izdano u: | Arthritis Res |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2000
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130132/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11094444/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/ar108 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|